Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Bioorg Med Chem. 2022 Feb 15;56:116627. doi: 10.1016/j.bmc.2022.116627. Epub 2022 Jan 14.
As our ongoing work on lathyrane diterpenoid derivatization, three series of lathyrane diterpenoid derivatives were designed and synthesized based combination principles, including pyrazole, thiazole and furoxan moieties. Biological evaluation indicated that compound 23d exhibited excellently inhibitory activity on LPS-induced NO production in RAW264.7 cells (IC = 0.38 ± 0.18 μM). The preliminary structure-activity relationships (SARs) suggested that phenylsulfonyl substituted furoxan moiety had the strongest ability to improve anti-inflammatory activity of lathyrane diterpenoids. Furthermore, compound 23d significantly reduced the level of ROS. Its molecular mechanism was related to inhibiting the transcriptional activation of Nrf2/HO-1 pathway. Based on these considerations, 23d might be a promising anti-inflammatory agent, which is noteworthy for further exploration.
在我们对拉蒂烷二萜衍生物的持续研究中,基于组合原理设计并合成了三个系列的拉蒂烷二萜衍生物,包括吡唑、噻唑和呋咱部分。生物评价表明,化合物 23d 对 LPS 诱导的 RAW264.7 细胞中 NO 的产生具有极好的抑制活性(IC = 0.38 ± 0.18 μM)。初步的构效关系(SARs)表明,苯磺酰基取代的呋咱部分具有最强的提高拉蒂烷二萜类化合物抗炎活性的能力。此外,化合物 23d 还显著降低了 ROS 的水平。其分子机制与抑制 Nrf2/HO-1 通路的转录激活有关。基于这些考虑,23d 可能是一种有前途的抗炎剂,值得进一步探索。